These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

576 related items for PubMed ID: 24477328

  • 1. Contradiction between in vitro and clinical outcome: intravenous followed by oral azithromycin therapy demonstrated clinical efficacy in macrolide-resistant pneumococcal pneumonia.
    Kohno S, Tateda K, Kadota J, Fujita J, Niki Y, Watanabe A, Nagashima M.
    J Infect Chemother; 2014 Mar; 20(3):199-207. PubMed ID: 24477328
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of azithromycin in the treatment of community-acquired pneumonia, including patients with macrolide-resistant Streptococcus pneumoniae infection.
    Yanagihara K, Izumikawa K, Higa F, Tateyama M, Tokimatsu I, Hiramatsu K, Fujita J, Kadota J, Kohno S.
    Intern Med; 2009 Mar; 48(7):527-35. PubMed ID: 19336954
    [Abstract] [Full Text] [Related]

  • 3. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ, Giménez MJ, Barberán J, Coronel P, Gimeno M, Aguilar L.
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of intravenous azithromycin followed by oral azithromycin for the treatment of acute pelvic inflammatory disease and perihepatitis in Japanese women.
    Mikamo H, Iwasaku K, Yamagishi Y, Matsumizu M, Nagashima M.
    J Infect Chemother; 2014 Jul; 20(7):429-35. PubMed ID: 24787738
    [Abstract] [Full Text] [Related]

  • 5. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
    Tellier G, Niederman MS, Nusrat R, Patel M, Lavin B.
    J Antimicrob Chemother; 2004 Aug; 54(2):515-23. PubMed ID: 15269191
    [Abstract] [Full Text] [Related]

  • 6. [In vitro resistance rates of Streptococcus pneumoniae and Haemophilus influenzae clinical isolates to the antibiotics used in therapy].
    Uncu H, Colakoğlu S, Turunç T, Demiroğlu YZ, Arslan H.
    Mikrobiyol Bul; 2007 Jul; 41(3):441-6. PubMed ID: 17933256
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children.
    Sunakawa K, Farrell DJ.
    Ann Clin Microbiol Antimicrob; 2007 Aug 13; 6():7. PubMed ID: 17697316
    [Abstract] [Full Text] [Related]

  • 8. Antibacterial activity and PK/PD of ceftriaxone against penicillin-resistant Streptococcus pneumoniae and beta-lactamase-negative ampicillin-resistant Haemophilus influenzae isolates from patients with community-acquired pneumonia.
    Ohno A, Ishii Y, Kobayashi I, Yamaguchi K.
    J Infect Chemother; 2007 Oct 13; 13(5):296-301. PubMed ID: 17982717
    [Abstract] [Full Text] [Related]

  • 9. [Azithromycin and bronchopulmonary infections].
    Leophonte P.
    Pathol Biol (Paris); 1995 Jun 13; 43(6):534-41. PubMed ID: 8539078
    [Abstract] [Full Text] [Related]

  • 10. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010].
    Wang H, Liu YL, Chen MJ, Xu YC, Sun HL, Yang QW, Hu YJ, Cao B, Chu YZ, Liu Y, Zhang R, Yu YS, Sun ZY, Zhuo C, Ni YX, Hu BJ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb 13; 35(2):113-9. PubMed ID: 22455967
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of intravenous sulbactam/ampicillin 3 g 4 times daily in Japanese adults with moderate to severe community-acquired pneumonia: a multicenter, open-label, uncontrolled study.
    Kohno S, Tateda K, Mikamo H, Kadota J, Niki Y, Itamura R.
    J Infect Chemother; 2015 Mar 13; 21(3):182-8. PubMed ID: 25533886
    [Abstract] [Full Text] [Related]

  • 12. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
    Pfaller MA, Farrell DJ, Sader HS, Jones RN.
    Clin Infect Dis; 2012 Sep 13; 55 Suppl 3():S187-93. PubMed ID: 22903951
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of moxifloxacin for treatment of penicillin-, macrolide- and multidrug-resistant Streptococcus pneumoniae in community-acquired pneumonia.
    Fogarty C, Torres A, Choudhri S, Haverstock D, Herrington J, Ambler J.
    Int J Clin Pract; 2005 Nov 13; 59(11):1253-9. PubMed ID: 16236076
    [Abstract] [Full Text] [Related]

  • 15. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].
    Melo-Cristino J, Fernandes ML, Serrano N, Grupo de Estudo Português de Bactérias Patogénicas Respiratórias.
    Acta Med Port; 2001 Nov 13; 14(5-6):459-68. PubMed ID: 11878155
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae.
    Siquier B, Sánchez-Alvarez J, García-Mendez E, Sabriá M, Santos J, Pallarés R, Twynholm M, Dal-Ré R, 620 Clinical Study Group.
    J Antimicrob Chemother; 2006 Mar 13; 57(3):536-45. PubMed ID: 16446376
    [Abstract] [Full Text] [Related]

  • 17. Nationwide, multicenter survey on the efficacy and safety of piperacillin for adult community-acquired pneumonia in Japan.
    Yamamoto Y, Watanabe A, Goto H, Matsushima T, Abe S, Aoki N, Shimokata K, Mikasa K, Niki Y, Kohno S.
    J Infect Chemother; 2012 Aug 13; 18(4):544-51. PubMed ID: 22618270
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
    Yang Q, Xu Y, Chen M, Wang H, Sun H, Hu Y, Zhang R, Duan Q, Zhuo C, Cao B, Liu Y, Yu Y, Sun Z, Chu Y.
    Diagn Microbiol Infect Dis; 2012 Jun 13; 73(2):187-91. PubMed ID: 22521692
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.